Marion E. Erlandson

1.5k total citations
38 papers, 1.1k citations indexed

About

Marion E. Erlandson is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Marion E. Erlandson has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 23 papers in Hematology and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Marion E. Erlandson's work include Hemoglobinopathies and Related Disorders (22 papers), Blood groups and transfusion (12 papers) and Erythrocyte Function and Pathophysiology (9 papers). Marion E. Erlandson is often cited by papers focused on Hemoglobinopathies and Related Disorders (22 papers), Blood groups and transfusion (12 papers) and Erythrocyte Function and Pathophysiology (9 papers). Marion E. Erlandson collaborates with scholars based in United States. Marion E. Erlandson's co-authors include Carl H. Smith, Gertrude Stern, Irving Schulman, Mary Allen Engle, Margaret W. Hilgartner, Philip Lanzkowsky, Virginia C. Canale, Mark New, Peter G. Steinherz and S. W. Moore and has published in prestigious journals such as New England Journal of Medicine, Circulation and Blood.

In The Last Decade

Marion E. Erlandson

34 papers receiving 927 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marion E. Erlandson United States 16 661 538 253 186 117 38 1.1k
Irving Schulman United States 23 472 0.7× 873 1.6× 258 1.0× 206 1.1× 179 1.5× 64 1.5k
Şînasi Özsoylu Türkiye 18 227 0.3× 532 1.0× 186 0.7× 77 0.4× 106 0.9× 140 1.1k
Haewon C. Kim United States 14 335 0.5× 490 0.9× 217 0.9× 78 0.4× 112 1.0× 29 1.1k
Gungor Karayalcin United States 18 255 0.4× 255 0.5× 124 0.5× 81 0.4× 126 1.1× 63 833
Yi‐Kong Keung United States 17 198 0.3× 379 0.7× 88 0.3× 72 0.4× 112 1.0× 55 820
Silvana Vigano’D’Angelo Italy 13 193 0.3× 881 1.6× 167 0.7× 27 0.1× 125 1.1× 15 1.2k
Neil A. Lachant United States 16 215 0.3× 334 0.6× 103 0.4× 114 0.6× 98 0.8× 51 990
Mary Jane Patch United States 14 254 0.4× 644 1.2× 76 0.3× 20 0.1× 176 1.5× 19 950
Maria Casteels‐Van Daele Belgium 18 102 0.2× 262 0.5× 166 0.7× 81 0.4× 170 1.5× 53 934
Ella H. Oppenheimer United States 16 87 0.1× 105 0.2× 240 0.9× 155 0.8× 493 4.2× 32 892

Countries citing papers authored by Marion E. Erlandson

Since Specialization
Citations

This map shows the geographic impact of Marion E. Erlandson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion E. Erlandson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion E. Erlandson more than expected).

Fields of papers citing papers by Marion E. Erlandson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion E. Erlandson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion E. Erlandson. The network helps show where Marion E. Erlandson may publish in the future.

Co-authorship network of co-authors of Marion E. Erlandson

This figure shows the co-authorship network connecting the top 25 collaborators of Marion E. Erlandson. A scholar is included among the top collaborators of Marion E. Erlandson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion E. Erlandson. Marion E. Erlandson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Canale, Virginia C., Peter G. Steinherz, Mark New, & Marion E. Erlandson. (1974). ENDOCRINE FUNCTION IN THALASSEMIA MAJOR. Annals of the New York Academy of Sciences. 232(1). 333–345. 92 indexed citations
2.
Lanzkowsky, Philip, et al.. (1969). Isolated Defect of Folic Acid Absorption Associated with Mental Retardation and Cerebral Calcification. Blood. 34(4). 452–465. 73 indexed citations
3.
Erlandson, Marion E.. (1967). Hematologic problems in the newborn. The Journal of Pediatrics. 71(1). 147–147. 7 indexed citations
4.
Erlandson, Marion E.. (1964). SURVIVAL RATES IN RH SENSITIZATION.. PubMed. 34. 436–7. 1 indexed citations
5.
Engle, Mary Allen, Marion E. Erlandson, & Carl H. Smith. (1964). Late Cardiac Complications of Chronic, Severe, Refractory Anemia with Hemochromatosis. Circulation. 30(5). 698–705. 209 indexed citations
6.
Blumberg, Baruch S., et al.. (1964). Multiple Antigenic Specificities of Serum Lipoproteins Detected with Sera of Transfused Patients. Vox Sanguinis. 9(2). 128–145. 41 indexed citations
7.
Blumberg, Baruch S., et al.. (1964). Multiple Antigenic Specificities of Serum LipoproteinsDetected with Sera of Transfused Patients. Vox Sanguinis. 9(2). 128–145. 1 indexed citations
8.
Erlandson, Marion E., et al.. (1964). Metabolism of Iron, Calcium and Magnesium in Homozygous Thalassemia*. Annals of the New York Academy of Sciences. 119(2). 769–775. 8 indexed citations
9.
Hilgartner, Margaret W., Marion E. Erlandson, & Carl H. Smith. (1963). The coagulation mechanism in patients with thalassemia major. The Journal of Pediatrics. 63(1). 36–45. 7 indexed citations
10.
Moore, S. W. & Marion E. Erlandson. (1963). Intramural Hematoma of the Duodenum. Annals of Surgery. 157(5). 798–809. 34 indexed citations
11.
Erlandson, Marion E.. (1963). Current status of exchange transfusion. The Journal of Pediatrics. 63(2). 357–360. 1 indexed citations
12.
Erlandson, Marion E., et al.. (1962). Studies on Congenital Hemolytic Syndromes. IV. Gastrointestinal Absorption of Iron. Blood. 19(3). 359–378. 111 indexed citations
13.
Hilgartner, Margaret W., et al.. (1961). A Comparison of the Paper and Starch Block Electrophoretic Methods for Determination of A2Hemoglobin. American Journal of Clinical Pathology. 35(1). 26–30. 7 indexed citations
14.
Hartmann, Ch., et al.. (1960). The clinical evaluation of 5-fluoro-2'-deoxyuridine in acute leukemia in children.. PubMed. 8. 84–96. 3 indexed citations
15.
Erlandson, Marion E., Irving Schulman, & Carl H. Smith. (1960). Studies on congenital hemolytic syndromes. III. Rates of destruction and production of erythrocytes in sickle cell anemia.. PubMed. 25. 629–44. 35 indexed citations
16.
Smith, Carl H., Marion E. Erlandson, Gertrude Stern, & Irving Schulman. (1960). The Role of Splenectomy in the Management of Thalassemia. Blood. 15(2). 197–211. 49 indexed citations
17.
Erlandson, Marion E., Irving Schulman, & Carl H. Smith. (1959). Studies on congenital hemolytic syndromes. II. Rates of destruction and production of erythrocytes in hereditary spherocytosis.. PubMed. 23(3). 462–75. 4 indexed citations
18.
Erlandson, Marion E. & Margaret W. Hilgartner. (1959). Hemolytic disease in the neonatal period and early infancy. The Journal of Pediatrics. 54(5). 566–585. 17 indexed citations
19.
Schulman, Irving, et al.. (1956). VASCULAR HEMOPHILIA. PEDIATRICS. 18(3). 347–361. 52 indexed citations
20.
Smith, Carl H., Irving Schulman, & Marion E. Erlandson. (1954). Round Table Discussion. PEDIATRICS. 14(6). 678–680.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026